Martin Albert

Martin Albert has a strong background in the pharmaceutical industry. Martin most recently worked as the Chief Scientific Officer at Zentiva since September 2017. Prior to that, Martin held various roles at Sanofi, including Head of Portfolio & Program Management for Sanofi Generics and Operation Excellence & Innovation Director. Martin also served as the Head of Business Development Europe at Glenmark Pharmaceuticals and as the Portfolio Building Director at Zentiva (a Sanofi Company). Martin started their career at Sandoz, where they worked in roles such as Head of Portfolio Management API, Sector Head Chemical Development, and Lab Head Chemical Development.

Martin Albert earned their Dr. degree in Technische Chemie from Technische Universität Graz between 1990 and 2000. Martin also attended the Max-Planck-Institut Mühlheim from 2001 to 2002, although no specific degree or field of study is mentioned for this period. Additionally, they briefly studied Chemie at Université de Rennes I in 1995.